 |
| Cipla Launches 'ViraGen' Covid-19 RT-PCR Test Kit In India |
ViraGen Test Kit: Drug major Cipla on Thursday announced the commercialization of its RT-PCR test kit 'ViraGen' for COVID-19 in India, in partnership with Ubio Biotechnology Systems.
"This launch will help address the current testing services and capacity issues while reaffirming the company's ongoing expansion in the diagnostic space," Cipla said in a regulatory filing. Cipla will launch the ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.
The company will commence the supply of the COVID-19 virus detection kit from May 25, 2021.
Umang Vohra, MD and Global CEO, Cipla, said, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against COVID-19.”